Maya Datt Joshi
Overview
Explore the profile of Maya Datt Joshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
506
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pal N, Mavi A, Kumar S, Kumar U, Joshi M, Saluja R
Heliyon
. 2021 May;
7(4):e06894.
PMID: 33937545
The prevalence of COVID-19 continues to rise with more than 114,315,846 million confirmed cases and 2,539,427 deaths worldwide by 3 March 2021 and this number kept on increasing day by...
2.
Rajabi H, Ahmad R, Jin C, Joshi M, Guha M, Alam M, et al.
Prostate
. 2012 Apr;
72(15):1659-68.
PMID: 22473899
Background: The mucin 1 (MUC1) heterodimeric oncoprotein is overexpressed in human prostate cancers with aggressive pathologic and clinical features. However, few insights are available regarding the functional role of MUC1...
3.
Rajabi H, Ahmad R, Jin C, Kosugi M, Alam M, Joshi M, et al.
J Biol Chem
. 2012 Feb;
287(13):10703-10713.
PMID: 22318732
MUC1 is a heterodimeric glycoprotein that is overexpressed in breast cancers. The present studies demonstrate that the oncogenic MUC1 C-terminal subunit (MUC1-C) associates with the TCF7L2 transcription factor. The MUC1-C...
4.
Ahmad R, Rajabi H, Kosugi M, Joshi M, Alam M, Vasir B, et al.
Sci Signal
. 2011 Feb;
4(160):ra9.
PMID: 21325207
Signal transducer and activator of transcription 3 (STAT3) is activated in human breast cancer and other malignancies. Mucin 1 (MUC1) is a heterodimeric cell surface glycoprotein that is overexpressed in...
5.
Rajabi H, Joshi M, Jin C, Ahmad R, Kufe D
Prostate
. 2011 Feb;
71(12):1299-308.
PMID: 21308711
Background: The MUC1 heterodimeric oncoprotein is aberrantly overexpressed in human prostate cancers with more aggressive pathologic and clinical features. However, the signals that regulate MUC1 expression in prostate cancer cells...
6.
Rajabi H, Jin C, Ahmad R, McClary C, Joshi M, Kufe D
Genes Cancer
. 2010 Aug;
1(1):62-68.
PMID: 20729973
The MUC1 oncoprotein is overexpressed in most human breast cancers by mechanisms that are incompletely understood. The microRNA, miR-125b, is downregulated in breast cancer cells. The present studies demonstrate that...
7.
Joshi M, Ahmad R, Yin L, Raina D, Rajabi H, Bubley G, et al.
Mol Cancer Ther
. 2009 Nov;
8(11):3056-65.
PMID: 19887552
Human prostate cancers are dependent on the androgen receptor for their progression. The MUC1 heterodimeric oncoprotein is aberrantly overexpressed in prostate cancers; however, it is not known if MUC1 is...
8.
Ahmad R, Raina D, Joshi M, Kawano T, Ren J, Kharbanda S, et al.
Cancer Res
. 2009 Aug;
69(17):7013-21.
PMID: 19706766
Nuclear factor-kappaB (NF-kappaB) is constitutively activated in diverse human malignancies. The mucin 1 (MUC1) oncoprotein is overexpressed in human carcinomas and, like NF-kappaB, blocks cell death and induces transformation. The...
9.
Raina D, Ahmad R, Joshi M, Yin L, Wu Z, Kawano T, et al.
Cancer Res
. 2009 Jun;
69(12):5133-41.
PMID: 19491255
The mucin 1 (MUC1) oncoprotein is aberrantly overexpressed by approximately 90% of human breast cancers. However, there are no effective agents that directly inhibit MUC1 and induce death of breast...